EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Factors of Pediatric Acute Myeloid Leukemia Patients with t(8;21) (q22;q22): A Single-Center Retrospective Study

Jiapeng Yang, Xiaohua Zhu, Honghong Zhang, Yang Fu, Zifeng Li, Ziping Xing iD, Yi Yu, Ping Cao, Jun Le, Junye Jiang, Jun Li, Hongsheng Wang und 1 weitere

Children · 17.05.2024 · 11 (5) · 605

DOI: 10.3390/children11050605 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Children, online erschienen am 17.05.2024. Verfasst von Jiapeng Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai 201102, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China, the National Natural Science Foundation of China, Shanghai Municipal Committee of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This retrospective study aimed to analyze the treatment effect and prognostic factors of pediatric acute myeloid leukemia (AML) patients with t(8;21). A total of 268 newly diagnosed pediatric AML (pAML) enrolled from 1 January 2005 to 31 December 2022 were retrospectively reviewed, and 50 (18.7%) patients harbored t(8;21) translocation. CR rate, OS, EFS, and RFS were assessed by multivariate Logistic and Cox regression models in these patients. Of the 50 patients, 2 patients abandoned treatment during the first induction course. Of the remaining 48 patients who received double-induction therapy and were included in the final analyses, CR1 and CR2 were 75.0% (36/48) and 95.8% (46/48), respectively. The overall three-year OS, EFS, and RFS were 68.4% (95% CI, 55.0–85.1), 64.2% (95% CI, 50.7–81.4), and 65.5% (95% CI, 51.9–82.8), respectively. The presence of loss of sex chromosome (LOS) at diagnosis (n = 21) was associated with a better 3-year OS [87.5% (95% CI, 72.7–100) vs. 52.7% (95% CI, 35.1–79.3), p = 0.0089], 3-year EFS [81.6% (95% CI, 64.7–100) vs. 49.7% (95% CI, 32.4–76.4), p = 0.023], and 3-year RFS [81.6% (95% CI, 64.7–100) vs. 51.7% (95% CI, 33.9–78.9), p = 0.036] than those without LOS (n = 27), and it was also an independent good prognostic factor of OS (HR, 0.08 [95% CI, 0.01–0.48], p = 0.005), EFS (HR, 0.22 [95% CI, 0.05–0.85], p = 0.029), and RFS (HR, 0.21 [95% CI, 0.05–0.90], p = 0.035). However, extramedullary leukemia (EML) featured the independent risk factors of inferior OS (HR, 10.99 [95% CI, 2.08–58.12], p = 0.005), EFS (HR, 4.75 [95% CI, 1.10–20.61], p = 0.037), and RFS (HR, 6.55 [95% CI, 1.40–30.63], p = 0.017) in pediatric individuals with t(8;21) AML. Further analysis of combining LOS with EML indicated that the EML+LOS− subgroup had significantly inferior OS (92.9%, [95% CI, 80.3–100]), EFS (86.2%, [95% CI, 70.0–100]), and RFS (86.2%, [95% CI, 80.3–100]) compared to the other three subgroups (all p < 0.001). LOS and EML are independent prognostic factors of OS, EFS, and RFS with t(8;21) pAML patients. LOS combined with EML may help improve risk stratification.

Schlagwörter

Stichwörter der Autor:innen

21)extramedullary leukemialoss of sex chromosomepediatric acute myeloid leukemiaprognosist(8

Autor:innen und Institutionen

  • Department of Hematology and Oncology, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai 201102, China.

ORCID-Profile: Ziping Xing

Förderung

  • the National Key Research and Development Program of China
  • the National Natural Science Foundation of China
  • Shanghai Municipal Committee of Science and Technology
  • Shanghai Hospital Development Center
  • the Cyrus Tang Foundation
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Cyrus Tang Foundation

Zitieren

APA

Yang, J., Zhu, X., Zhang, H., Fu, Y., Li, Z., Xing, Z., Yu, Y., Cao, P., Le, J., Jiang, J., Li, J., Wang, H., & Zhai, X. (2024). Prognostic Factors of Pediatric Acute Myeloid Leukemia Patients with t(8;21) (q22;q22): A Single-Center Retrospective Study. Children, 11(5), 605. https://doi.org/10.3390/children11050605

Vancouver

Yang J, Zhu X, Zhang H, Fu Y, Li Z, Xing Z, et al. Prognostic Factors of Pediatric Acute Myeloid Leukemia Patients with t(8;21) (q22;q22): A Single-Center Retrospective Study. Children. 2024;11(5):605. doi:10.3390/children11050605

BibTeX
@article{Yang2024,
  author = {Yang, Jiapeng and Zhu, Xiaohua and Zhang, Honghong and Fu, Yang and Li, Zifeng and Xing, Ziping and Yu, Yi and Cao, Ping and Le, Jun and Jiang, Junye and Li, Jun and Wang, Hongsheng and Zhai, Xiaowen},
  title = {Prognostic Factors of Pediatric Acute Myeloid Leukemia Patients with t(8;21) (q22;q22): A Single-Center Retrospective Study},
  journal = {Children},
  year = {2024},
  volume = {11},
  number = {5},
  pages = {605},
  doi = {10.3390/children11050605}
}
Kostenlos starten →